Dividends Calendar Earnings Calendar
ADGI

ADGI | Adagio Therapeutics Inc

Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 617.45M
  • Prev closed:
  • Open: 6.33
  • High: 16.41
  • Low: 6.25
  • 52 week low: 5.57
  • 52 week high: 78.82
  • Dividends:No Dividends

Next ER: February 21, 2022 



Top Stories (ADGI)

    Company Profile

    Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's portfolio of antibodies has been optimized using Adimab's industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio's portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 2, 2022
    November 15, 2021-0.98 / -0.735- / -
    September 20, 2021-0.18 / -0.795- / -
    July 16, 2021-2.14 / -- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 21, 2022 5.99 6.11
    6.40
    5.73
    1.59M -6.99%
    Jan 20, 2022 6.44 5.62
    6.99
    5.61
    9.30M 16.04%
    Jan 19, 2022 5.55 5.61
    5.76
    5.36
    3.14M 0.91%
    Jan 18, 2022 5.50 5.43
    5.90
    5.29
    3.05M -3.51%
    Jan 14, 2022 5.70 5.08
    5.90
    4.92
    7.83M 8.37%
    Jan 13, 2022 5.26 6.76
    6.77
    5.18
    24.70M -9.78%
    Jan 12, 2022 5.83 6.05
    6.06
    5.72
    1.80M -3.16%
    Jan 11, 2022 6.02 6.03
    6.22
    5.87
    1.66M -1.47%
    Jan 10, 2022 6.11 5.86
    6.16
    5.58
    2.05M 3.04%
    Jan 7, 2022 5.93 6.06
    6.49
    5.84
    1.59M -3.1%
    view more
    NASDAQ - Nasdaq Stock Market

    News

    News for (ADGI)

    This company doesn't provide a dividend.


    Talk about Adagio Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 21, 2022 (Same day)

    sci we sui hlx qlgn ttnp lcid twks edr adgi seat 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 25
    HOLD 75
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.